MET (MetLife) 3-Year RORE % : 29.29% (As of Mar. 2026)


MET MetLife Inc MET
76 GF Score
Price $90.06
GF Value $90.01
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is MetLife 3-Year RORE %?

MetLife MET +3.28% 76 3-Year RORE % is 29.29 as of Mar. 2026. GuruFocus rates MET with a GF Score™ of 76/100 and a GF Value™ of $90.01 (Fairly Valued). The stock has 8 warning signs investors should review. Among 474 Insurance companies, MetLife ranks better than 71.73% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. MetLife's 3-Year RORE % for the quarter that ended in Mar. 2026 was 29.29%.

The industry rank for MetLife's 3-Year RORE % or its related term are showing as below:

MET's 3-Year RORE % is ranked better than
71.73% of 474 companies
in the Insurance industry
Industry Median: 11.865 vs MET: 29.29

MetLife  (NYSE:MET) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


MetLife 3-Year RORE % Related Terms


MetLife 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for MetLife's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MetLife 3-Year RORE % Chart

MetLife Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.90 2.67 -59.95 -0.46 47.59

MetLife Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.10 34.74 39.23 47.59 29.29

MET vs AFL, PRU, UNM: 3-Year RORE % Comparison

For the Insurance - Life subindustry, MetLife's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MetLife 3-Year RORE % vs Insurance Industry

For the Insurance industry and Financial Services sector, MetLife's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where MetLife's 3-Year RORE % falls into.


MET
76GF Score
MetLife Inc MET
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MetLife 3-Year RORE % Calculation

MetLife's 3-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( 5.16-2.91 )/( 14.215-6.532 )
=2.25/7.683
=29.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of 29.29 mean?
MetLife (MET) has a 3-Year RORE % of 29.29 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on MetLife and its competitors. According to the industry distribution chart, MetLife ranks #134 out of 474 companies in the Insurance industry, placing it in the top 28.3%.
Is MetLife's 3-Year RORE % too high?
MetLife's current 3-Year RORE % is 29.29. The Insurance industry median 3-Year RORE % is 11.87. MetLife's value of 29.29 is 146.9% above this industry median. Based on the distribution chart, MetLife ranks #134 out of 474 companies in the Insurance industry, which is above the industry midpoint. Overall, MetLife has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MetLife's 3-Year RORE % compare to AFL and PRU?
According to the Insurance industry distribution chart, MetLife ranks #134 out of 474 companies for 3-Year RORE %. This puts MetLife in the upper half of its industry. The industry median 3-Year RORE % is 11.87. MetLife's value of 29.29 is 146.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for an Insurance company?
The median 3-Year RORE % among Insurance companies is 11.87, based on 474 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MetLife's current 3-Year RORE % of 29.29 is 146.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on MetLife and its competitors. For the Insurance industry, the median 3-Year RORE % is 11.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MetLife's current 3-Year RORE % is 29.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MetLife stock overvalued right now?
Based on GuruFocus' analysis, MetLife (MET) is currently considered Fairly Valued. The stock's GF Value™ is $90.01, compared to a current price of $90.06 — trading 0.1% above its estimated fair value. The current 3-Year RORE % is 29.29 and 146.9% above the Insurance industry median of 11.87. MetLife's overall GF Score™ is 76/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For MetLife (MET), the current 3-Year RORE % is 29.29 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MetLife (MET) Overvalued in 2026?

Based on GuruFocus' analysis, MetLife stock appears to be overvalued. The current stock price of $90.06 is trading 0.1% above its estimated GF Value™ of $90.01. GuruFocus considers MetLife to be Fairly Valued.

Key valuation signals for MET:

  • 3-Year RORE %: 29.29
  • GF Value™: $90.01 vs. price of $90.06 (0.1% above fair value)
  • GF Score™: 76/100 with 8 warning signs
  • Industry Position: 146.9% above the Insurance median (#134 of 474)

No single metric tells the full story. See the MET stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MetLife Business Description

Address 200 Park Avenue, New York, NY, USA, 10166-0188
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
76GF Score

Get the complete analysis for MET

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$90.06
Price
$90.01
GF Value